Detalhe da pesquisa
1.
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Clin Infect Dis
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598658
2.
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
N Engl J Med
; 385(25): 2348-2360, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587382
3.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Lancet
; 397(10269): 99-111, 2021 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306989
4.
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Lancet
; 397(10277): 881-891, 2021 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617777
5.
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
Ann Intern Med
; 174(2): 221-228, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090877
6.
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
Ann Intern Med
; 174(8): 1118-1125, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844575
7.
Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma.
Eur Respir J
; 58(6)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34112734
8.
Benralizumab efficacy for patients with fixed airflow obstruction and severe, uncontrolled eosinophilic asthma.
Ann Allergy Asthma Immunol
; 124(1): 79-86, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31626906
9.
Blood eosinophil count group shifts and kinetics in severe eosinophilic asthma.
Ann Allergy Asthma Immunol
; 125(2): 171-176, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32334141
10.
Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma.
Ann Allergy Asthma Immunol
; 122(5): 478-485, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30802500
11.
Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma.
Eur Respir J
; 52(4)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30139780
12.
Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.
Ann Allergy Asthma Immunol
; 120(5): 504-511.e4, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29409951
13.
Structured Benefit-risk assessment: a review of key publications and initiatives on frameworks and methodologies.
Pharm Stat
; 15(4): 324-32, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981683
14.
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
Pharmacoepidemiol Drug Saf
; 23(7): 667-78, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821575
15.
Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.
Pharmacoepidemiol Drug Saf
; 23(9): 974-83, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043919
16.
Multivariate Cluster Analyses to Characterize Asthma Heterogeneity and Benralizumab Responsiveness.
J Allergy Clin Immunol Pract
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38663470
17.
Use of CompEx in eosinophilic patients with severe, uncontrolled asthma on benralizumab.
ERJ Open Res
; 10(2)2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500798
18.
Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data.
Epidemics
; 47: 100768, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643547
19.
Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
Arthritis Rheum
; 64(7): 2387-97, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22275142
20.
Dupilumab as a treatment for cutaneous immune-related adverse events induced by immune checkpoint inhibitors: A case series and review of the literature.
SAGE Open Med Case Rep
; 11: 2050313X231195462, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37654554